时间标签：数据日期 2026-11-01 · 生成时间 2026-11-01 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/10/31–2026/11/01 ｜ 情报发生日期 2026-11-01
证据级别：摘要级。本条依据 PubMed 结构化摘要与元数据撰写，付费墙全文未获取、未逐节核验，本站未做任何数值推算补全。
研究问题
Physical frailty has been linked to cardiovascular-kidney-metabolic (CKM) multimorbidity, but the role of cognitive frailty and its dynamic changes in CKM progression remains unclear.；These findings suggest that monitoring changes in cognitive function over time could help identify individuals at high risk of CKM multimorbidity, and that interventions aimed at improving cognitive health may need to achieve meaningful…
方法
This cohort study included participants aged ≥45 years from the CHARLS (2011-2018).；Among 9,816 participants, 3,836 were included in baseline CKM analysis and 1,891 in transition analysis.；In this study, we analysed data from nearly 10,000 middle-aged and older adults in China to understand whether cognitive frailty increases the risk of developing cardiovascular-kidney-metabolic (CKM) multimorbidity, a cluster of conditions…
核心结论
Both RCF (HR=2.74, 95%CI:2.25-3.34) and PRCF (HR=2.51, 95%CI:1.96-3.21) were associated with increased CKM risk (both P<0.001).；RCF-to-Robust improvement reduced CKM risk by 56% (HR=0.44, 95%CI:0.23-0.85, P=0.015), while deterioration markedly increased risk (HR≈5.3, P<0.001).；Substantial improvement (Δscore=-3) significantly reduced risk, whereas minor improvements showed protective trends without statistical significance.；Cognitive frailty is independently associated with CKM multimorbidity progression.；We found that people with cognitive frailty had significantly higher risks of developing CKM multimorbidity.；More importantly, we found that the magnitude of change in cognitive function added prognostic information on top of its direction-greater worsening tracked with higher CKM risk.
局限
（原文未给出可直接抽取的对应表述）
对本项目的价值
高价值：CHARLS 全国队列显示认知衰弱及其变化与心血管—肾脏—代谢多病共病相关，把「认知 + 躯体衰弱」复合表型确立为高危分层工具。 ｜ 价值分 1.0/5（★☆☆☆☆）
全文来源
未取到全文 → 本卡为摘要级解读，未核验全文
原文题录
- 英文标题：Association of Cognitive Frailty and Its Changes With Cardiovascular-Kidney-Metabolic Multimorbidity: Findings From the CHARLS Study.
- 期刊与标识：Ageing research reviews · PMID 42962771 · DOI 10.1016/j.arr.2026.103433
A 级证据分级：A 级（同行评议人体研究）
本文属人体研究证据，但需注意：观察性或小样本干预的结论不等于已证实临床获益；效应量与长期安全性仍需更大规模、更长随访的试验验证。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」（SOP §4.2 摘要级）撰写，依据期刊公开摘要与 PubMed 元数据；付费墙全文未获取之处已标注「待补全文」，未做任何数值推算补全。